(Just The News)—When Health and Human Services Secretary Robert F. Kennedy Jr. shifted nearly $500 million designated for mRNA vaccine development to “safer, broader vaccine platforms that remain effective even as viruses mutate,” predictable wailing followed from the public health establishment and mainstream media but also some old-guard conservatives.
National Review editors praised COVID-19 vaccines for their belatedly alleged protections against severe outcomes, citing President Biden’s Centers for Disease Control and Prevention for the claim they reduced hospitalization and death by 70% among those vaccinated, even as the editors acknowledged the virus naturally became “less severe over time.”
The publication’s intern even called COVID vaccines, whose inability to stop infection and transmission was known to then-CDC Director Rochelle Walensky a month after emergency use authorization, “the most phenomenal medical breakthrough of the 21st century.”
Yet peer-reviewed global research keeps identifying severe adverse events following mRNA vaccination in some groups at low risk from COVID, and a German-led paper in the official journal of the International Union of Immunological Societies offers a causal explanation.
“Our findings reveal that numerous off-target products are produced by mRNA-based corona vaccines following translation of the encoded spike monomers,” said researchers affiliated with institutes on physiology, medical informatics, pharmacology and “Molecular and Translational Therapeutic Strategies” in Germany and Hungary.
Click this link for the original source of this article.
Author: Just The News
This content is courtesy of, and owned and copyrighted by, https://americafirstreport.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
